Delmo Walter Eva Maria, Javier Mariano Francisco, Sander Frank, Hartmann Bernd, Ekkernkamp Axel, Hetzer Roland
Trauma Surgery Center Berlin, Berlin, Germany.
Herzzentrum Cottbus, Cottbus, Germany.
Ann Thorac Surg. 2016 Dec;102(6):2062-2069. doi: 10.1016/j.athoracsur.2016.04.057. Epub 2016 Jun 23.
Primary cardiac tumors in infants and children are extremely rare; hence, there is very little literature available, and most knowledge is based on collections of case reports. This report is a comprehensive review of our 26-year experience with primary cardiac tumors in children with emphasis on surgical indications, strategies, and long-term outcome.
Between 1986 and 2012, 47 children (mean age 5.9 ± 2.4 months; range, 1 day to 17 years) underwent either subtotal or total resection of cardiac tumors (rhabdomyoma, 13; fibroma, 12; teratoma, 9; myxoma, 8; hemangioma, 2; rhabdomyosarcoma, 1; non-Hodgkin's lymphoma, 1; lymphangioma, 1). The majority were diagnosed by echocardiography (n = 33). Clinical patterns were varied: 40 had an atypical heart murmur and 6 were asymptomatic. Outflow tract obstruction of more than 30 mm Hg was present in 11 children. Three patients had abnormal coronary arteries secondary to pressure from tumor bulk. Indications of resection were hemodynamic/respiratory compromise, severe arrhythmia, and a significant embolization risk. Strategy of resection varied according to location and hemodynamic status without damage to adjacent structures.
Morbidity included bleeding in a patient and a transient low output state in another. A 5-month-old infant with left ventricular fibroma underwent left ventricular assist device implantation secondary to failure from weaning off cardiopulmonary bypass, and she eventually underwent heart transplantation 17 days later. Early mortality (n = 2, 4.2%) included a 5-month-old infant who underwent complete resection of rhabdomyoma located in the left ventricle, with concomitant pulmonary valve replacement; unfortunately, he underwent left ventricular assist device implantation for postoperative heart failure and died on the 13th postoperative day. An 8-month-old child with 3 cm × 4 cm fibroma obstructing the right ventricular outflow tract compressing the right coronary artery died of severe right-side heart failure on the 13th postoperative day. One late death (2.1%) occurred; a 16-year-old with non-Hodgkin's lymphoma died 7 months after the surgery. Mean duration of follow-up is 11.6 ± 3.5 years. All survivors (93.4%) are well, free of tumor-related symptoms and tumor recurrence/progression, even when resection was incomplete.
This study illustrates that although primary cardiac tumors in infants and children have a wide and unusual spectrum of clinical presentation, an individualized approach to tumor resection allows restoration of an adequate hemodynamic function and satisfactory long-term, tumor-free outcome.
婴幼儿原发性心脏肿瘤极为罕见,因此相关文献极少,大多数知识基于病例报告的汇总。本报告全面回顾了我们26年来治疗儿童原发性心脏肿瘤的经验,重点关注手术指征、策略和长期预后。
1986年至2012年间,47例儿童(平均年龄5.9±2.4个月;范围1天至17岁)接受了心脏肿瘤的次全切除或全切除(横纹肌瘤13例;纤维瘤12例;畸胎瘤9例;黏液瘤8例;血管瘤2例;横纹肌肉瘤1例;非霍奇金淋巴瘤1例;淋巴管瘤1例)。大多数通过超声心动图诊断(n = 33)。临床症状多样:40例有非典型心脏杂音,6例无症状。11例儿童存在超过30 mmHg的流出道梗阻。3例患者因肿瘤压迫导致冠状动脉异常。切除指征为血流动力学/呼吸功能受损、严重心律失常和显著的栓塞风险。根据肿瘤位置和血流动力学状态制定切除策略,同时避免损伤相邻结构。
并发症包括1例患者出血和另1例短暂的低心排血量状态。1例5个月大的左心室纤维瘤婴儿因脱离体外循环失败而植入左心室辅助装置,最终在17天后接受心脏移植。早期死亡2例(4.2%),其中1例5个月大的婴儿接受了位于左心室的横纹肌瘤完全切除并同期置换肺动脉瓣,不幸的是,他因术后心力衰竭接受左心室辅助装置植入,术后第13天死亡。1例8个月大的儿童,其3 cm×4 cm的纤维瘤阻塞右心室流出道并压迫右冠状动脉,术后第13天死于严重的右侧心力衰竭。1例晚期死亡(2.1%),1例16岁的非霍奇金淋巴瘤患者术后7个月死亡。平均随访时间为11.6±3.5年。所有幸存者(93.4%)情况良好,无肿瘤相关症状,无肿瘤复发/进展,即使切除不完全。
本研究表明,尽管婴幼儿原发性心脏肿瘤临床表现广泛且不寻常,但个体化的肿瘤切除方法可恢复足够的血流动力学功能,并获得满意的长期无瘤预后。